EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Design, Synthesis, and Anti-Tyrosinase, Anti-Melanogenic, and Antioxidant Activities of Novel (Z)-3-Benzyl-5-Benzylidene-2-Thioxothiazolidin-4-One Analogs

Hyeon Seo Park, Hee Jin Jung iD, Hye Soo Park, Hye Jin Kim, Yujin Park, Pusoon Chun iD, Hae Young Chung iD, Hyung Ryong Moon iD

Molecules · 2025

DOI: 10.3390/molecules30030517 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Hyeon Seo Park und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Manufacturing Pharmacy, College of Pharmacy and Research Institute for Drug Development, Pusan National University, Busan 46241, Republ…. Hauptthemen laut MEDLINE: Monophenol Monooxygenase, Antioxidants, Enzyme Inhibitors, Drug Design. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundatioin of Korea (NRF) grant funded by the Korean government (MIST), Basic Science Research Program through the National Research Foundation (NRF) of Korea funded by the Ministry of Education, National Research Foundation of Korea (NRF).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To discover novel anti-melanogenic compounds with tyrosinase inhibitory activity, (Z)-3-benzyl-5-benzylidene-2-thioxothiazolidin-4-one ((Z)-BBTT) analogs 1–12, designed based on the hybrid structure of a β-phenyl-α,β-unsaturated carbonyl motif and a 3-benzyl-2-thioxothiazolidin-4-one scaffold, were synthesized as novel tyrosinase inhibitors. Of the 12 analogs, 2 (6 and 8) showed mushroom tyrosinase inhibitory activity similar to that of kojic acid, a representative tyrosinase inhibitor, and 3 analogs (1–3) exhibited mushroom tyrosinase inhibitory activity that was more potent than that of kojic acid. In particular, analog 3 revealed highly potent inhibition with an IC50 value of 90 nM, which was 214 times lower than that of kojic acid (IC50 value = 19.22 μM). A kinetic study using mushroom tyrosinase and analogs 1–3 and 6 demonstrated that these analogs were competitive inhibitors, which was further supported by in silico studies. Analogs 1 and 3 have strong anti-melanogenic potency in B16F10 mammalian cells owing to their anti-tyrosinase activity without perceptible cytotoxicity in melanoma cells (B16F10) and the main epidermal cells (HaCaT). Moreover, analog 3 exhibited strong antioxidant capacity, scavenging reactive oxygen species, 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) cation radical, and 2,2-diphenyl-1-picrylhydrazyl radical, partially contributing to its anti-melanogenic effect. (Z)-BBTT analogs, including analog 3, may be promising candidates for inhibiting melanin production.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Monophenol MonooxygenaseAntioxidantsEnzyme InhibitorsDrug DesignThiazolidinesAgaricalesHumansAnimalsMelaninsCell Line, TumorPyronesMiceStructure-Activity RelationshipMolecular StructureMolecular Docking Simulation

Stichwörter der Autor:innen

(Z)-BBTTB16F10 cellsmelanintyrosinaseβ-phenyl-α,β-unsaturated carbonyl

Substanzen

Monophenol MonooxygenaseAntioxidantsEnzyme Inhibitorskojic acidMelaninsPyronesThiazolidines

Autor:innen und Institutionen

  • Department of Manufacturing Pharmacy, College of Pharmacy and Research Institute for Drug Development, Pusan National University, Busan 46241, Republic of Korea.
  • Department of Medicinal Chemistry, New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu 41061, Republic of Korea.
  • College of Pharmacy and Inje Institute of Pharmaceutical Sciences and Research, Inje University, Gimhae 50834, Republic of Korea.
  • Department of Pharmacy, College of Pharmacy and Research Institute for Drug Development, Pusan National University, Busan 46241, Republic of Korea.

ORCID-Profile: Hee Jin Jung, Pusoon Chun, Hae Young Chung, Hyung Ryong Moon

Förderung

  • National Research Foundatioin of Korea (NRF) grant funded by the Korean government (MIST)
  • Basic Science Research Program through the National Research Foundation (NRF) of Korea funded by the Ministry of Education
  • National Research Foundation of Korea (NRF)
  • Basic Science Research Program

Zitieren

APA

Park, H. S., Jung, H. J., Park, H. S., Kim, H. J., Park, Y., Chun, P., Chung, H. Y., & Moon, H. R. (2025). Design, Synthesis, and Anti-Tyrosinase, Anti-Melanogenic, and Antioxidant Activities of Novel (Z)-3-Benzyl-5-Benzylidene-2-Thioxothiazolidin-4-One Analogs. Molecules. https://doi.org/10.3390/molecules30030517

Vancouver

Park HS, Jung HJ, Park HS, Kim HJ, Park Y, Chun P, et al. Design, Synthesis, and Anti-Tyrosinase, Anti-Melanogenic, and Antioxidant Activities of Novel (Z)-3-Benzyl-5-Benzylidene-2-Thioxothiazolidin-4-One Analogs. Molecules. 2025. doi:10.3390/molecules30030517

BibTeX
@article{Park2025,
  author = {Park, Hyeon Seo and Jung, Hee Jin and Park, Hye Soo and Kim, Hye Jin and Park, Yujin and Chun, Pusoon and Chung, Hae Young and Moon, Hyung Ryong},
  title = {Design, Synthesis, and Anti-Tyrosinase, Anti-Melanogenic, and Antioxidant Activities of Novel (Z)-3-Benzyl-5-Benzylidene-2-Thioxothiazolidin-4-One Analogs},
  journal = {Molecules},
  year = {2025},
  doi = {10.3390/molecules30030517}
}
Kostenlos starten →